← Back to all trials
Not Yet Recruiting
NCT05653310
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Tradipitant for Functional Dyspepsia
Conditions: Functional Dyspepsia
Sex: All
Ages: 18 Years – 70 Years
Phase: PHASE2
Enrollment: 60
Sponsor: Vanda Pharmaceuticals
Location: United States
Summary
To evaluate the effects of tradipitant relative to placebo on gastric motor functions, satiation, and postprandial symptoms in patients with functional dyspepsia.
Eligibility Criteria
Inclusion Criteria:Able to provide written consentBody Mass Index (BMI) of 18-35 kg/m2Absence of other diseases which could interfere with interpretation of study resultsExclusion Criteria:Current H. pylori infectionPregnancy or nursingRecent history of Alcohol Use Disorder or Substance Use Disorder
Source: ClinicalTrials.gov (NCT05653310). StuddyBuddy aggregates publicly available trial information.
